Targeting hyperactivation of the <scp>AKT</scp> survival pathway to overcome therapy resistance of melanoma brain metastases

Heike Niessner(University of Tübingen), Friedegund Meier(University of Tübingen)
Cancer Medicine
December 12, 2012
Cited by 152


Related Papers